VEXAS Syndrome: A Newly Recognized Entity to Consider in Systemic Disease-Associated Interstitial Lung Disease [0.03%]
血管性埃森综合征：一种应考虑的系统性疾病相关的间质性肺病实体
Eva Cabrera-Cesar,Sara Sánchez Martin,Gloria Moreno Carrasco
Eva Cabrera-Cesar
Lung Function and the GOLD ABE Classification: Do We Need to "Go Back to the Future"? [0.03%]
肺功能和GOLD ABE分类：我们需要“回顾未来”吗？
Rafael Golpe,Juan Marco Figueira-Gonçalves
Rafael Golpe
[Theoretical Basis for Developing Cardiopulmonary Clinical Units in Patients with COPD and CVD] [0.03%]
[COPD和心血管疾病患者心肺临床护理单元构建的理论依据]
Javier de Miguel-Díez,Juan José Gómez Doblas,Salud Santos Pérez et al.
Javier de Miguel-Díez et al.
Chronic obstructive pulmonary disease is one of the leading causes of morbidity and mortality worldwide, and its frequent coexistence with cardiovascular diseases significantly increases the risk of exacerbations, hospital readmissions, and...
Does Exercise Overcome Pollution? Why Physical Activity is Still Our Best Medicine [0.03%]
运动能够战胜污染吗？为什么身体活动仍然是最好的“良药”
Pilar Cejudo Ramos,Rafael Rivilla Rivilla,Itxaso Sayago Reza
Pilar Cejudo Ramos
Rapidly Progressive Interstitial Lung Disease Associated With Anti-MDA5 Dermatomyositis [0.03%]
与抗MDA5皮肤肌炎相关的迅速进展性间质性肺病
Eric Andrey Rodríguez-Vega,Miguel Octavio Gaxiola-Gaxiola,Heidegger Norberto Mateos Toledo
Eric Andrey Rodríguez-Vega
[Knowledge and attitudes about social determinants of respiratory health in SEPAR members] [0.03%]
西班牙呼吸病学会会员关于影响肺部健康的社会决定因素的知识和态度调查
Joan B Soriano,Carlos Almonacid,Isabel Urrutia-Landa et al.
Joan B Soriano et al.
Knowledge and perceptions of social determinants of respiratory health (SDRH) were assessed among SEPAR members using an anonymous online survey. 293 professionals responded (4.8% of members). Although 98.6% recognized that SDRH affects cli...
Longitudinal Evolution of Phenotypes in Severe Asthma: Clinical Implications for Personalized Medicine [0.03%]
重度哮喘表型的纵向演变及其在个性化医疗中的临床意义
Francisco Javier Álvarez-Gutiérrez,Marina Blanco Aparicio,José Valverde Molina
Francisco Javier Álvarez-Gutiérrez
Patient-Centred Strategies: The Cornerstone of Bronchiectasis Management [0.03%]
以患者为中心的策略：支气管扩张症管理的基础
Beatriz Herrero-Cortina
Beatriz Herrero-Cortina
Clinical Benefits of Tezepelumab in a Real-World Cohort of Patients With Severe Uncontrolled Asthma in Castilla-La Mancha, Spain [0.03%]
西班牙卡斯蒂利亚-拉曼查重度不受控制的哮喘患者的现实队列中Tezepelumab的临床益处
Carlos Bujalance-Cabrera,María José Espinosa de Los Monteros-Garde,Diego Morena-Vallés et al.
Carlos Bujalance-Cabrera et al.
Introduction: Tezepelumab is an anti-thymic stromal lymphopoietin monoclonal antibody approved for the treatment of severe uncontrolled asthma regardless of inflammatory phenotype. Although its efficacy has been demonstra...
M ª Auxiliadora Romero Falcón,Carmen Gómez Martín,Juan Francisco Medina Gallardo et al.
M ª Auxiliadora Romero Falcón et al.
Introduction: There is controversy over the effect that swimming in indoor pools can have on lung function and on bronchial inflammation parameters in asthma. The objective of this study was to observe the effect of recre...